Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Michael Hiltzik: This life-saving drug will cost a record $2.8 million. Who will pay the price?

For the estimated 1,500 Americans suffering from a blood disorder known as beta thalassemia, the Food and Drug Administration's approval Aug. 17 of the drug Zynteglo was almost unalloyed good news.

Los Angeles Times

Junshi Biosciences Hits Revenue Roadblock Amid Covid Drug Delay

Key Takeaways: The company logged a revenue fall of 55% in the first half of the year and posted a loss of $131 million Phase 3 clinical trials for its Covid-19 oral drug wrapped up in May but the company has still not yet filed an application to market the…

Benzinga

Zenara launches generic version of Pfizer Covid drug Paxlovid

Sets MRP at ₹5,200 for a box of 20 Nirmatrelvir tablets, 10 tablets of Ritonavir

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

IRPC preparing to buy speciality polymer assets

IRPC, the petrochemical arm of national oil and gas conglomerate PTT Plc, is preparing to buy new assets in the speciality polymer manufacturing segment as it steps up efforts to earn more revenue from high-margin products.

Bangkok Post

Trump Ally Dr. Oz Hyped Unapproved 'Covid Cures' From Companies He Owns Shares Of

Republican Pennsylvania Senate candidate Dr. Mehmet Oz owns shares of two companies he publicly supported, touting their drugs as potential Covid-19 treatments — even though the drugs weren't approved by the U.S. Food and Drug Administration (FDA).

Benzinga

Losses widen at Shield Therapeutics though sales and prescriptions of its drugs grow

The maker of iron deficiency tablets says there is a huge unmet need for its products in the US were about 20 million people suffer anaemia

Birmingham Post

Canadian Psychedelics Company Reduces Manufacturing Time Of MDMA By Two Thirds

Nirvana Life Sciences Inc. (CSE: NIRV) announced that it has engineered a method that reduces the manufacturing time of MDMA by two thirds.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Controversial ALS drug from Amylyx gets rare second FDA meeting

Amylyx Pharmaceuticals Inc.’s controversial treatment for amyotrophic lateral sclerosis won the support of a panel of U.S. regulatory advisers, putting the product on track for likely clearance.

Tribune News Service

HRT medicine to be sold without prescription for the first time

It is the first time women will be able to buy a certain type of hormone replacement therapy from a high street chemist without a prescription.

The Independent UK

New malaria vaccine comes a step closer as experts say it’s ‘the best yet’

Chance to eradicate diseases such as malaria could be lost and UK innovation squandered if global health investment is cut, jab co-creator tells PM

The Guardian - UK

Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies

PharmaTher Holdings (OTCQB: PHRRF), the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study of its ketamine patch, KETARX, in minipigs.

Benzinga

Government admits 50 firms were in VIP lane for test and trace contracts

Health department had denied Covid testing priority lane but new disclosure lists firms including lab behind false negatives

The Guardian - UK

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Pfizer’s (NYSE:PFE) lead drug GBS6 or PF-06760805 for the prevention of invasive GBS disease due to the vaccine serotypes in newborns and young infants by active immunization of their mothers during pregnancy. Pfizer shares traded in a…

Benzinga

No, COVID-19 isn’t winding down, scientists say, predicting it’ll be around the rest of our lives

Even with new boosters, experts predict the scourge that’s already lasted longer than the 1918 flu pandemic will linger far into the future. Here’s why.

Chicago Sun-Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

ALS drug gets rare second review at high-stakes FDA meeting

The Food and Drug Administration is holding an unusual second meeting to review a closely watched drug for the illness known as Lou Gehrig’s disease

Benzinga

E-Cigarette Maker To Pay Over $430M To Settle Multi-State Vaping Inquiry, Cannabis Investors Need To Pay Attention

E-cigarette producer Juul Labs agreed to pay $438.5 million to 34 states and territories to sort out a two-year bipartisan investigation into its marketing and sales practices.

Benzinga

Mark Cuban Says 'Pharma Bro' Martin Shkreli Inspired His Cost Plus Drug Company

Billionaire investor and Dallas Mavericks owner Mark Cuban, who has revolutionized healthcare with his “Cost Plus Drug Company,” has taken inspiration from someone who is an antithesis of sorts, the Shark Tank investor revealed to Re

The Times of India

Unapproved antibiotic usage on rise in India; Azithromycin, cefixime most used tablets, finds study

A research study published in The Lancet has talked about one of the most serious habits of Indians which should have been talked about earlier. The study says close to 50% of the antibiotic formulations used in India's private sector in 2019 were not approved by the central drug regulator.

Get all your
news in one place.

100's of premium titles.
One news app.

Birmingham Post

Tissue Regenix narrows losses but lingering impact of Covid weighs on healthcare market

The Leeds-based creator of regenerative medical devices increased revenues across the first half of 2022

Salon

Fear-mongering about fentanyl for kids

One expert characterized the DEA's claims as propaganda that was "divorced from reality"

Benzinga

Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees

Cathie Wood’s ARK Genomic Revolution EFT has been making big investments in the psychedelics sector since February 2022, most notably in A

Nottingham Post

Talented cricketer was supplying 'laughing gas' to Nottingham students

Canisters of the drug were found in a car

Reuters

Argentina hikes biofuel prices for domestic market

Argentina's government on Tuesday increased domestic prices of biodiesel for blending with diesel, as well as for bioethanol made from sugarcane and corn.

Benzinga

Tetra Partners With Cellvera To Develop An Oral Treatment For COVID-19

Tetra Bio-Pharma Inc.

Daily Mirror

When will Omicron boosters be available? Who is eligible for Covid jab and how to book

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a second Coronavirus booster vaccine to target the Omicron variant ahead of the autumn booster programme

1 … 132 133 134 135

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Amyotrophic lateral sclerosis

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.